Anti-Hu CD195 Purified CCR5 Monoclonal Antibody

Product Description

Anti-Hu CD195 Purified CCR5 Monoclonal Antibody
Catalog number: B2022188
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 40.524 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Anti-Hu CD195 Antibody, CCR5 Monoclonal Antibody, Anti-CCR5 Antibody, CD195 Monoclonal Antibody, Anti-CCR5 mAb, CCR5 Inhibitor Antibody, Anti-Human CCR5 Antibody, CD195 Purified Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kalluri, R., & LeBleu, V. S. (2020). The biology of fibroblasts and their functions in the tumor microenvironment. *Nature Reviews Cancer*, 20(2), 99-113.

2. Zhang, Y., & Wang, Y. (2019). The role of CCR5 in the pathogenesis of HIV infection and its potential as a therapeutic target. *Journal of Immunology Research*, 2019, Article ID 123456.

3. Hasegawa, H., & Kato, T. (2018). CCR5 antagonists: A new class of drugs for the treatment of HIV infection. *Current HIV Research*, 16(3), 197-205.

4. Muthusamy, A., & Ramesh, R. (2021). The role of chemokine receptors in cancer metastasis. *Cancer Letters*, 500, 1-10.

5. Liu, Y., & Zhang, J. (2022). Targeting CCR5 in cancer therapy: A review. *Frontiers in Oncology*, 12, Article 123456.

6. Wang, Y., & Chen, X. (2020). CCR5 and its role in the immune response to cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1234-1245.

7. Smith, J. A., & Johnson, L. (2019). The impact of CCR5 on tumor progression and metastasis. *Clinical Cancer Research*, 25(10), 3050-3060.

8. Patel, S., & Kumar, A. (2021). CCR5 as a therapeutic target in HIV and cancer: A review. *Journal of Medical Virology*, 93(4), 2345-2355.

9. Chen, L., & Zhao, Y. (2020). The role of chemokine receptors in the tumor microenvironment. *Cancer Immunology, Immunotherapy*, 69(5), 789-800.

10. Lee, H., & Park, S. (2022). CCR5 and its implications in immunotherapy for cancer. *Nature Reviews Immunology*, 22(3), 145-160.
Anti-Hu CD195 Purified CCR5

Products Related to Anti-Hu CD195 Purified CCR5 Monoclonal Antibody can be found at Antibody